IL6 and schizophrenia: Furthermore, findings from Mendelian randomization (34, 35, 36) studies suggest that genetically determined elevated peripheral IL-6 levels may causally contribute to the development of both schizophrenia and MDD, with therapeutic potential shown in recent trials (37,38).